11 results for "Li-Chun Lu"
Showing 1–11 · 0.24 seconds · RSS
-
Journal Article
Recurrent Gastric Cancer Initially Presenting with Dysphagia induced by Idiopathic Inflammatory Myositis: A Case Report
We present the case of a 51-year-old female patient who was diagnosed with gastric cancer and subsequently underwent surgical resection, followed by adjuvant chemotherapy. Despite these interventions, the disease recurred, manifesting as laryngeal weakness and clinical features indicative of an…
-
Journal Article
Tumor Lysis Syndrome in a Super-responder to Chemoimmunotherapy for Nasopharyngeal Carcinoma: A Case Report
We present the case of a 54-year-old male with nasopharyngeal cancer accompanied by huge liver metastasis, an extremely high Epstein–Barr virus viral load, and B symptoms. Despite aggressive hydration and close laboratory monitoring, he developed tumor lysis syndrome (TLS) and acute kidney injury…
-
Journal Article
Unfavorable Tumor Responses to Immunotherapy in the Liver: Lessons Learned from Clinical and Preclinical Studies
Objective: Immunotherapy with immune checkpoint inhibitors (ICIs) has become a standard of care for many malignancies. The tumor microenvironment (TME) varies across different organs and affects tumor initiation, progression, and treatment outcomes. Organ-specific differential responses to ICIs…
-
Journal Article
Perivascular epithelioid cell tumor of the gastrointestinal tract
Perivascular epithelioid cell tumor (PEComa) is a rare subtype of soft tissue sarcoma that coexpresses melanocytic and smooth muscle markers. We report a case of malignant PEComa arising from the gastrointestinal tract. Definitive diagnosis of malignant PEComa is based on pathological examination…
-
Journal Article
Shp2 Deficiency in Kupffer Cells and Hepatocytes Aggravates Hepatocarcinogenesis by Recruiting Non-Kupffer MacrophagesSummary
Background & Aims: Complex communications between hepatocytes and Kupffer cells (KCs) are known to drive or suppress hepatocarcinogenesis, with controversial data in the literature. In previous experiments that aimed to decipher hepatocyte/KC interactions, we unexpectedly unveiled a…
-
Journal Article
Atezolizumab plus bevacizumab combination enables an unresectable hepatocellular carcinoma resectable and links immune exclusion and tumor dedifferentiation to acquired resistance
Abstract We reported a patient with unresectable hepatocellular carcinoma (HCC) who initially received 15 cycles of atezolizumab plus bevacizumab combination and had best tumor response of partial response, but later experienced disease progression. After subsequent surgical resection, the patient…
-
Journal Article
Improved survival with adding-on strategy after failure of nanoliposomal irinotecan plus 5-fluorouracil and leucovorin in metastatic pancreatic adenocarcinoma
Background: Nanoliposomal irinotecan (nal-IRI) plus 5-fluorouracil and leucovorin (FL) is indicated after progression on gemcitabine-based therapy in patients with metastatic pancreatic ductal adenocarcinoma (PDAC). However, salvage therapy after nal-IRI/FL failure remains to be established…
-
Journal Article Full text
Methodological Quality and Clinical Translation of Deep Learning in Traditional Chinese Medicine Disease Diagnosis: A Systematic Review and Validation Gap Analysis
Traditional Chinese Medicine (TCM) diagnosis is characterized by substantial subjectivity and inter-practitioner variability. Although deep learning (DL) offers potential for standardization and intelligent diagnostic support, its methodological rigor and clinical applicability remain unclear. This…
-
Journal Article
Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinoma
Immune checkpoint inhibitors have limited efficacy in the treatment of pancreatic ductal adenocarcinoma (PDAC). We investigated prognostic markers for nivolumab-based therapy in advanced or recurrent PDAC. Consecutive patients receiving nivolumab-based therapy at our institution between 2015 and…
-
Journal Article Full text
DNA damage response pathway regulates Nrf2 in response to oxidative stress
Nrf2 acts as a transcriptional master regulator to orchestrate antioxidant responses and maintain redox balance. However, the cellular pathway for translating oxidative stress signals into Nrf2-dependent antioxidant responses remain incompletely understood. Here, we show that reactive oxygen…
-
Journal Article
Outcomes of post-immunotherapy durable responders of advanced hepatocellular carcinoma - with emphasis on locoregional therapy for oligoprogression
Introduction The progression patterns, dispositions, and outcomes of patients with advanced hepatocellular carcinoma (HCC) who achieved durable responses with immunotherapy remain poorly characterized. Methods Patients with advanced HCC who received immune checkpoint inhibitor (ICI)-based…